Research And Development Expense Excluding Acquired In Process Cost

Name: AnaptysBio, Inc. Research And Development Expense Excluding Acquired In Process Cost by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

AnaptysBio, Inc.·Business Segments·2 segments·Rolls up to R&D

Breakdown

Segment	FY'25
Biopharma Company	$139.61M
Royalty Management Company	-$3.64M
Total	$135.97M

All segment values are derived from annual filings.

Segments

Biopharma CompanyView metric

Royalty Management CompanyView metric